Mitochondrial modifying nutrients in treating chronic fatigue syndrome: A 16-week open-label pilot study

These preliminary findings suggest that a combination nutraceutical compound of mitochondrial agents may improve CFS symptoms. Further investigation is warranted in a larger double-blind RCT.